SBI Pharmaceuticals

Japan
Tokyo, Tokyo, Japan

Company profile

SBI Pharmaceuticals company profile

SBI Pharmaceuticals is a treatment foundation, and treatment methods vary greatly depending on whether or not the cancer has invaded the muscle layer. Non-muscle invasive bladder cancer accounts for approximately half of all cases. Bladder tumour resection (also known as bladder cancer endoscopic resection, TURBT) removes the cancer while leaving the bladder intact.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Founded
2008-01-01, Year

Headquarters

Country code
JP
Continent
Asia

Capital profile

Funding and company signals

Articles
3

Categories and groups

Founders and investors

No public relation records are available.